AVT-80 (vedolizumab biosimilar)
/ Alvotech
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
February 12, 2025
AVT80-GL-P01: Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio
(clinicaltrials.gov)
- P1 | N=351 | Recruiting | Sponsor: Alvotech Swiss AG | Not yet recruiting ➔ Recruiting
Enrollment open
December 13, 2024
AVT80-GL-P01: Study to Investigate Comparative Pharmacokinetics, Safety, Immunogenicity and Tolerability Between AVT80 and Entyvio
(clinicaltrials.gov)
- P1 | N=351 | Not yet recruiting | Sponsor: Alvotech Swiss AG
New P1 trial
1 to 2
Of
2
Go to page
1